Bilcare Global Clinical Supplies forms corporate advisory board
Dated: 5/13/2008
Bilcare Global Clinical Supplies, a leading single-source provider of clinical trial services, has formed its first corporate Advisory Board.
Bilcare Limited’s chairman and managing director Mohan Bhandari announced former Pfizer president John LaMattina, Ph.D., and Waterloo Institute of Nanotechnology Executive Director Arthur Carty Ph.D., D.Sc, as the board’s inaugural members.
Dr LaMattina will serve as its chairman. The advisory board was created to provide the Bilcare GCS Senior management team with independent scientific industry expertise and insight to assist in the accomplishment of scientific and business objectives in support of the company’s global mission.
Dr. LaMattina had a distinguished 30-year career at Pfizer where he held various positions, including Senior Vice President of Pfizer Inc., and President of Pfizer Global Research and Development.
Dr Carty is the first Executive Director of the Waterloo Institute of Nanotechnology and the former National Science Advisor to Canada’s Prime Minister.
